Key facts and Forecast
Financial results for Q2 2025
- Strong sales in Process Solutions and for blockbusters Mavenclad and Erbitux, sustained demand for Semiconductor Materials
- Acquisition of SpringWorks and divestment of Surface Solutions successfully closed, now included in guidance
- Net sales organically +2.0% to € 5.3 billion; foreign exchange effects of –4.2%
- EBITDA pre organically +4.6% to € 1.5 billion; foreign exchange effects of –7.2%
Forecast 2025
- Organic sales growth range for Group narrowed; raised expectations for Group, Life Science and Healthcare EBITDA pre
Overview: business performance in Q2 2025
| Q2 2025 (in € billion) | Change (in %, compared to Q2 2024) | Organic change (in %, compared to Q2 2024) |
|---|---|---|---|
Group net sales |
5.3 |
–1.8 |
2.0 |
EBITDA pre |
1.5 |
–3.1 |
4.6 |
Life Science sales |
2.3 |
0.4 |
3.7 |
Healthcare sales |
2.1 |
–1.6 |
3.6 |
Electronics sales |
0.9 |
–7.4 |
–5.6 |
We have delivered solid underlying sales and earnings growth. By standing on three pillars – Life Science, Healthcare and Electronics – we are, as a Group, better able to withstand the geopolitical, economic and currency swings that are buffeting companies around the world.
Results & Beyond: Our CEO Speaks
Our CEO Belén Garijo comments on the Q2 2025 results.
-
![Brochure title]()
Half-yearly Financial Report 2025 (PDF)
Download (PDF)Detailed information about the development of our business in the first half of 2025.
ADDITIONAL INFORMATION
Downloads for the Media
- Press Release (PDF)
- Presentation for the Media (PDF)
- Further downloads are available in the Investor Relations Section
Conference calls for the media and analysts
- Conference call for the media
The conference call for the media will take place at 9:30 a.m. (CEST)
- Conference call for analysts
The conference call for analysts can be followed live via webcast at 2 p.m. (CEST)
Related News
View All News-
Press Releases
Q2 2025: Merck KGaA, Darmstadt, Germany, Delivers Profitable Organic Growth ...
Strong sales in Process Solutions and for blockbusters Mavenclad and Erbitux, sustained demand for Semiconductor Materials.
2025/08/07
Upcoming Events
View All EventsOur Q3 2025 results will be published on November 13, 2025, at 7 a.m. (CET). Our conference call for the media will take place at 09:30 a.m. (CET), and the conference call for analysts at 2 p.m. (CET).
Our Q4 2025 results will be published on March 5, 2026, at 7 a.m. (CET). Our press conference will take place at 10:00 a.m. (CET), and the conference call for analysts at 2 p.m. (CET).
Annual Reports Archive
Find previous Annual Reports, Corporate Governance Reports & Statements in our archive.
Read more
Share Price
Our interactive Share Price Tool provides you with all the information you need. You can retrace our development within the last ten years or follow it in real time – or compare our share price to various indices.
Check Share Price